Thermo Fisher Scientific to Sell Microbiology Business in $1.08B Deal – What It Means for Contract Labs
The $1.075 billion sale of Thermo Fisher's antimicrobial susceptibility testing and culture media unit to private equity raises pressing questions about supply continuity, vendor relationships, and what comes next for the contract labs that depend on these products









